Skip to content

Posts related to ‘Opioid abuse’

Search
Filter
  •  | 
View
June 14, 2018
Tracey Davanport
Vice President Clinical Operations
Early nurse engagement

Early nurse engagement makes a valuable impact in 3 key areas Recent analysis of Sedgwick’s claims data shows that employers using 24/7 clinical consultation for workplace injuries saw 34% lower incurred costs than those using an intake process with…

June 14, 2018 by Tracey Davanport, Vice President Clinical Operations
April 26, 2018
Paul Peak
AVP Clinical Pharmacy
Putting safety first: National Prescription Drug Take Back Day 2018

Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be Saturday, April 28 from 10 a.m. – 2 p.m. In 2010, the DEA started org…

April 26, 2018 by Paul Peak , AVP Clinical Pharmacy
October 27, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Safety made simple: National Prescription Drug Take Back Day

Sedgwick routinely reminds clients and colleagues about the U.S. Drug Enforcement Administration’s (DEA’s) National Prescription Drug Take Back Days. The next Take Back Day will be this Saturday, October 28 from 10 a.m. – 2 p.m. In 2010, the DEA st…

October 27, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
September 14, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
A portrait of opioid use disorder

A portrait of opioid use disorder Read part one of Rachel's story here. Rachel was once a vibrant gardener, grandmother and worker. Regrettably, following an injury, she became one of a growing number of those suffering from opioid use disorder (…

September 14, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
August 31, 2017
Dr. Reema Hammoud
Director Clinical Pharmacy
Rachel’s story: A portrait of opioid use disorder

Rachel enjoyed gardening and canning vegetables. She enjoyed cooking, taking walks and spending time with her grandchildren. After she was injured at work, she was optimistic about making a speedy recovery. She was 53 years old and had always stayed …

August 31, 2017 by Dr. Reema Hammoud, Director Clinical Pharmacy
June 01, 2017
Dr. Paul Peak
Director Clinical Pharmacy
Prescribed DUI: An alcohol-free danger

When it comes to getting the attention of the media and the public, not many things work better than an unfiltered, celebrity mugshot. When Tiger Woods was arrested on Memorial Day for driving under the influence, his mugshot and the story of his a…

June 01, 2017 by Dr. Paul Peak, Director Clinical Pharmacy
May 17, 2017
Edward Canavan
VP Workers’ Compensation Practice and Compliance
The basics of complex claims

Most workers’ compensation claims do not start out as complex. They become complex over time due to specific drivers that increase costs and duration. Being able to recognize and resolve these drivers at the right time will help reduce a claim’s like…

May 17, 2017 by Edward Canavan, VP Workers’ Compensation Practice and Compliance
March 08, 2017
Luke Parnell, pharmacy program liaison
We’re not talking peanuts: Carfentanil, fentanyl and heroin

Carfentanil is a synthetic opioid that is 80 times more potent than fentanyl and 8,000 times more potent than heroin. Having been created and used as an elephant tranquilizer in China, it has now found its way into the hands of the public. This dru…

March 08, 2017 by Luke Parnell, pharmacy program liaison
May 12, 2016
Dr. Paul Peak
Director Clinical Pharmacy
Over-the-counter problem no longer under the radar

Three weeks ago, I was wrapping up a discussion with a client and fellow Sedgwick colleagues on the opioid epidemic. Someone in the room received the unexpected text that Prince had died. In the next few moments, without any other information, my fel…

May 12, 2016 by Dr. Paul Peak, Director Clinical Pharmacy
April 04, 2016
Dr. Teresa Bartlett
Senior Medical Officer
Dangerous prescribing practices and at-risk patients – a look at best practices

It was my privilege to present along with Dr. Paul Peak of Sedgwick at the 2016 National RX Drug and Heroin Summit in Atlanta, Georgia to discuss dangerous prescribing practices and at-risk patients. The conference was highlighted by a public ap…

April 04, 2016 by Dr. Teresa Bartlett, Senior Medical Officer
February 19, 2016
Jim Harvey
VP Client Services
Combating prescription drug abuse

Last year, Dr. Reema Hammoud of Sedgwick shared a blog regarding National Prescription Drug Take-Back Day. The next National Prescription Drug Take-Back Day, sponsored by the U.S. Drug Enforcement Administration (DEA), will be held April 30, 2016. Ho…

February 19, 2016 by Jim Harvey, VP Client Services
August 10, 2015
Tracey Radford, VP Managed Care Client Services
Sedgwick partners with medical directors on opioid management

It is possible that 2015 will be the year remembered as the turning point in addressing the opioid and narcotic epidemic in the United Sates. This year, almost every conference, publication and industry expert has addressed the topic. Just last mon…

August 10, 2015 by Tracey Radford, VP Managed Care Client Services
July 17, 2015
James Harvey, SVP, Managed Care Products & Product Development
Opioid medications: Gateways to heroin use?

According to the Centers for Disease Control and Prevention (CDC), 46 people in the U.S. die from an overdose of prescription painkillers every day.[1] Deaths from prescription painkiller overdoses have increased more than 400% among women and 2…

July 17, 2015 by James Harvey, SVP, Managed Care Products & Product Development
April 29, 2015
Jim Ryan
President, Casualty
You can’t manage what you don’t understand

We are in a time unlike any other in our industry. The pace and the reach of emerging risks make our heads spin. Each day the news brings new reports on topics that we know will impact the businesses we are all looking to protect. This year at RIMS…

April 29, 2015 by Jim Ryan, President, Casualty
February 26, 2015
Dr. Paul Peak
Director Clinical Pharmacy
Zohydro ER gets FDA approval…but will it really help prevent abuse?

On January 30, 2015 the Food and Drug Administration (FDA) approved a reformulated version of Zohydro ER (a long-acting, single-entity hydrocodone product) that is designed to possess abuse-deterrent properties. When the FDA originally approve…

February 26, 2015 by Dr. Paul Peak, Director Clinical Pharmacy
Load more
End of results.
Loading...